Unlike sBTLA, Programmed Death 1 (sPD-1) concentrations were lower in patients with sepsis and septic shock than in healthy control subjects, with no correlation to disease severity, and neither sPD-1 was a good biomarker to diagnose sepsis in critically ill patients. This evidence concerns the gene HOXD13 and Sepsis.